CN103520216A - Probiotic human injection - Google Patents
Probiotic human injection Download PDFInfo
- Publication number
- CN103520216A CN103520216A CN201310144567.1A CN201310144567A CN103520216A CN 103520216 A CN103520216 A CN 103520216A CN 201310144567 A CN201310144567 A CN 201310144567A CN 103520216 A CN103520216 A CN 103520216A
- Authority
- CN
- China
- Prior art keywords
- human
- probiotic
- probiotic bacteria
- bacteria
- damaged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a probiotic human injection, and relates to an injection for treating high-risk diseases of cancers, phthisis and AIDS (Acquired Immune Deficiency Syndrome). Only a part of focus of infection can be cut off by employing a western medicine surgery; human cells, and tissues and organs are damaged, probiotic bacteria in the body are killed, and the human immunity is damaged when germs and viruses are killed by the Chinese-western drugs. The incubation periods of the cancers and AIDS are 7-8 years, and the cancers and AIDS cannot be cured within a day, so that the Chinese-western drugs are theories and basis in fact for the incurable high-risk diseases. The probiotic human injection is injected all over a human body, and directly achieves the focus of infection; the human cells, and tissues and organs are not damaged; the injured cells are repaired; the probiotic bacteria in the body are not damaged. The human immune function is enhanced by probiotics; the germs and viruses are treated by bacteria; the sufferer inevitably quickly recovers along with gradual reduction of the germs and viruses in the body. Therefore, the probiotic human injection is the theory of curing the high-risk diseases.
Description
Affiliated technical field
The present invention relates to cancer, pulmonary tuberculosis, the high-risk treatment for diseases injection of acquired immune deficiency syndrome (AIDS).
Technical background
Cancer, pulmonary tuberculosis, an acquired immune deficiency syndrome (AIDS) world medicine difficult problem, operation can only cut-out focus, Chinese and western drugs kills pathogenic bacteria virus in body, harm people somatic cell simultaneously, and histoorgan, kills again probiotic bacteria, destroy immune function of human body, high-risk disease is difficult to the theory of curing, firm basis.
Summary of the invention
The technical solution used in the present invention: extract, cultivate probiotic bacteria, probiotic bacteria is made injection.Someone foretells that probiotic bacteria injects human vein, suffers from septicemia! Conclusion should be after scientific experiments.
Beneficial effect of the present invention: probiotic oral is slow to high-risk disease curative effect, probiotic bacteria human injection agent, is expelled to and in body, spreads all over the through focus of whole body, the somatic cell of not hurting sb.'s feelings, histoorgan, repairs damaged cell, and body probiotic bacteria does not kill a person, enhancing immunity, with the bacterium bacterium virus of curing the disease, in body, pathogenic bacteria virus reduces gradually, and damaged cell is repaired, the inevitable quick recovery of patient, micro-ecological medical science is to cure high-risk disease rationale.
The specific embodiment
1. produce bifidobacterium bifidum, bacillus acidophilus, streptococcus thermophilus, the probiotic bacterias such as fragile hundred million bacillus, extract edible fungi, plant mushroom probiotic bacteria, three kinds of probiotic group are combined into one group, or a kind of probiotic bacteria, make multiple types probiotic bacteria human injection agent, kill to the ill various pathogenic bacteria virus.
2. probiotic bacteria human injection agent is injected in animal body, medical observation check, draws after medical science conclusion, is applied to clinical trial, confirms pathogenic bacteria that various probiotic bacteria is suited the medicine to the illness virus.
3. for the treatment of acquired immune deficiency syndrome (AIDS), add taboo food: animal oil, various meat, fowl egg, Aquatic product, seafood.Must change clothes underwear, underwear every day.Duty is washed bedding, clothes, and shower, flowing water duty is washed one's hands.Chinese medicinal formulae: Herba Portulacae 30g, Rhizoma Smilacis Glabrae 30g, Flos Lonicerae 15g, Herba Taraxaci 15g, Radix Glycyrrhizae 6g, divides 20 parts after evenly mixing, approximately 50 ℃ of a medicine 300mml water microwave heatings, drink portion three every day, drinks front microwave heating.Health has the part of festering that 1~3 kind, fresh mushroom is mashed and applied in affected part moisturizing, changes every day to apply and deals carefully with for 1~2 time.
Claims (3)
1. probiotic bacteria human injection agent is by bifidobacterium bifidum, bacillus acidophilus, streptococcus thermophilus, probiotic bacteria and the edible fungis such as fragile hundred million bacillus, the probiotic bacteria that plant mushroom extracts, makes probiotic bacteria human injection agent, it is characterized in that the somatic cell of not hurting sb.'s feelings, histoorgan, repairs damaged cell, and body probiotic bacteria does not kill a person, with the bacterium bacterium virus of curing the disease, in human body, pathogenic bacteria virus reduces gradually, and immune function of human body strengthens, the inevitable quick recovery of patient.
2. according to described in 1, Chinese medicinal formulae, fresh mushroom is characterized in that killing inside and outside pathogenic bacteria virus, plays auxiliary therapeutic action.
3. according to described in 1, avoid food, its feature prevents interference treatment, gets rid of the difficulty that increases treatment of AIDS.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310144567.1A CN103520216A (en) | 2013-04-08 | 2013-04-08 | Probiotic human injection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310144567.1A CN103520216A (en) | 2013-04-08 | 2013-04-08 | Probiotic human injection |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103520216A true CN103520216A (en) | 2014-01-22 |
Family
ID=49922803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310144567.1A Pending CN103520216A (en) | 2013-04-08 | 2013-04-08 | Probiotic human injection |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103520216A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105213433A (en) * | 2015-11-06 | 2016-01-06 | 王益超 | A kind of compositions being used for the treatment of autism, recurrent abortion and infertility |
CN106038608A (en) * | 2016-06-18 | 2016-10-26 | 柳志信 | Microbial injection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101269098A (en) * | 2007-03-23 | 2008-09-24 | 中天生物科技股份有限公司 | Sanqi fermentation liquor with effect of inhibiting cancer cell and preparation method thereof |
CN103356716A (en) * | 2013-07-18 | 2013-10-23 | 吴炳新 | Fermented composition of multiple probiotics and composite medicinal and edible fungi, and preparation method and application thereof |
-
2013
- 2013-04-08 CN CN201310144567.1A patent/CN103520216A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101269098A (en) * | 2007-03-23 | 2008-09-24 | 中天生物科技股份有限公司 | Sanqi fermentation liquor with effect of inhibiting cancer cell and preparation method thereof |
CN103356716A (en) * | 2013-07-18 | 2013-10-23 | 吴炳新 | Fermented composition of multiple probiotics and composite medicinal and edible fungi, and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
周蓓莉 等: "《食用菌的益生元效应研究进展》", 《食品科学》, vol. 32, no. 15, 31 December 2011 (2011-12-31), pages 303 - 307 * |
杨月欣 等: "《1996~2007年中国保健食品原料调查分析——营养素和中草药原料状况分析》", 《卫生研究》, vol. 39, no. 2, 31 March 2010 (2010-03-31), pages 132 * |
韩英: "《微生态制剂——益生菌治疗炎症性肠病的作用机理研究进展》", 《中国医药导刊》, vol. 8, no. 5, 31 December 2006 (2006-12-31) * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105213433A (en) * | 2015-11-06 | 2016-01-06 | 王益超 | A kind of compositions being used for the treatment of autism, recurrent abortion and infertility |
CN112402461A (en) * | 2015-11-06 | 2021-02-26 | 王益超 | Composition for treating autism social interaction disorder |
CN106038608A (en) * | 2016-06-18 | 2016-10-26 | 柳志信 | Microbial injection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520216A (en) | Probiotic human injection | |
CN103385999B (en) | Chinese medicine composition for treating acute mastitis | |
CN104873760A (en) | Health Chinese coffee for expelling parasites and preparation method thereof | |
CN103341068B (en) | Traditional Chinese medicine composition for treating amygdalitis | |
CN105749088A (en) | Traditional Chinese medicine composition for treating mange and acariasis of fur animals and preparation method and application thereof | |
CN104161248B (en) | A kind of medicine and the food that can treat diarrhea due to damp-heat | |
CN103520220A (en) | Self-treatment for acquired immune deficiency syndrome | |
CN104306897A (en) | Traditional Chinese medicine composition for treating climacterium syndrome | |
CN103918891A (en) | Chicken feed | |
CN104706719A (en) | Capsule for treating waist pain | |
CN106581241A (en) | Burn and scald treating traditional Chinese medicine composition | |
CN104027555A (en) | Traditional Chinese medicine for treating acute mastitis | |
CN104288723A (en) | Diet formula for treating dysmenorrhea | |
CN104510894A (en) | Chinese herbal medicine aromatherapy medicine | |
CN104042888A (en) | Traditional Chinese medicine for treating swine enzootic pneumonia | |
CN104274773A (en) | Traditional Chinese medicine for treating cancers and resisting viruses and preparation method thereof | |
CN102441139B (en) | Traditional Chinese medicinal enema for treating infantile dysentery | |
CN105311124A (en) | Prescription for treating urinary tract infection | |
CN106215025A (en) | Broad-spectrum antiseptic Traditional Chinese medicine disinfectant and preparation method | |
CN105770832A (en) | Traditional Chinese medicine composition for treating abdominal distension | |
CN105079082A (en) | Traditional Chinese medicine for treating pediatric acute appendicitis | |
CN103893289B (en) | A kind of Chinese medicine for the treatment of child's neck chronic lymphadenitis | |
CN105079141A (en) | Tibetan veterinary medicine combination for treating yak pneumonia and preparation method and application thereof | |
CN1311844C (en) | Powder of Chinese traditional medicine 'Ganfukang' for treating liver disease | |
CN103599156A (en) | Wet beriberi therapeutic drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140122 |